July 20, 2015 article Open access NY-ESO-1–specific TCR–engineered T cells mediate sustained antigen-specific antitumor effects in myeloma Nature Medicine DOI: 10.1038/nm.3910 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 17 stored of 857 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Temperature-based MHC class-I multimer peptide exchange for human HLA-A, B and C 2026 eLife preprint Biochemistry, Genetics and Molecular Biology vaccines and immunoinformatics approaches Open access 0 citations Temperature-based MHC class-I multimer peptide exchange for human HLA-A, B and C 2025 eLife preprint Biochemistry, Genetics and Molecular Biology vaccines and immunoinformatics approaches Open access 0 citations Temperature-based MHC class-I multimer peptide exchange for human HLA-A, B and C 2025 eLife preprint Biochemistry, Genetics and Molecular Biology vaccines and immunoinformatics approaches Open access 0 citations CAR-mediated target recognition limits TCR-mediated target recognition of TCR- and CAR-dual-receptor-edited T cells 2025 Molecular Therapy article Medicine CAR-T cell therapy research Open access 8 citations Generation of effective and specific human TCRs against tumor/testis antigen NY-ESO-1 in mice with humanized T cell recognition system 2024 Frontiers in Immunology article Immunology and Microbiology Immunotherapy and Immune Responses Open access 6 citations Temperature-based MHC class-I multimer peptide exchange for human HLA-A, B and C. 2024 bioRxiv (Cold Spring Harbor Laboratory) preprint Biochemistry, Genetics and Molecular Biology vaccines and immunoinformatics approaches Open access 0 citations TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast Cancer 2024 Cancer Discovery article Medicine CAR-T cell therapy research Open access cited by 2 patents 14 citations Minor histocompatibility antigens to predict, monitor or manipulate GvL and GvHD after allogeneic hematopoietic cell transplantation 2024 Best Practice & Research Clinical Haematology article Medicine Hematopoietic Stem Cell Transplantation Open access 7 citations Reassessing human MHC-I genetic diversity in T cell studies 2024 Scientific Reports article Biochemistry, Genetics and Molecular Biology Race, Genetics, and Society Open access 11 citations TCR-engineered T-cells directed against Ropporin-1 constitute a safe and effective treatment for triple-negative breast cancer in near-clinical models 2024 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine CAR-T cell therapy research Open access 1 citations Reassessing Human Genetic Diversity in T Cell Studies. 2023 Research Square preprint Biochemistry, Genetics and Molecular Biology Race, Genetics, and Society Open access 0 citations High-affinity CD8 variants enhance the sensitivity of pMHCI antigen recognition via low-affinity TCRs 2023 Journal of Biological Chemistry article Immunology and Microbiology T-cell and B-cell Immunology Open access 9 citations WT1-specific TCRs directed against newly identified peptides install antitumor reactivity against acute myeloid leukemia and ovarian carcinoma 2022 Journal for ImmunoTherapy of Cancer article Immunology and Microbiology Immunotherapy and Immune Responses Open access cited by 6 patents 26 citations T cell receptor engineering of primary NK cells to therapeutically target tumors and tumor immune evasion 2022 Journal for ImmunoTherapy of Cancer article Immunology and Microbiology Immune Cell Function and Interaction Open access cited by 6 patents 34 citations Comparing CAR and TCR engineered T cell performance as a function of tumor cell exposure 2022 OncoImmunology article Medicine CAR-T cell therapy research Open access cited by 2 patents 60 citations T cells targeted to TdT kill leukemic lymphoblasts while sparing normal lymphocytes 2021 Nature Biotechnology article Medicine CAR-T cell therapy research Open access cited by 7 patents 36 citations A matter of life or death: targeting MCL-1 in multiple myeloma 2021 dissertation Biochemistry, Genetics and Molecular Biology Cell death mechanisms and regulation Open access 0 citations 17 results Cited by imported patents 2 (EPO, DOI in their cited literature) T CELL RECEPTORS DIRECTED AGAINST CANCER-ASSOCIATED ANTIGENS AND USES THEREOF 2024 WO2024101994A1 +1 publications Chemistry & metallurgy 2 offices T CELL RECEPTORS DIRECTED AGAINST JCHAIN AND USES THEREOF 2023 EP4479142A1 +2 publications Chemistry & metallurgy 3 offices References 0